Kanabo Group plc (KNB) ORD GBP0.025
Kanabo Group PLC, formerly Spinnaker Opportunities Plc, is a United Kingdom-based medical cannabis company. The Company is principally focused on distribution of cannabis-derived products for medical patients, and non- tetrahydrocannabinol (THC) products for Cannabidiol (CBD) consumers. It has developed a formula for sleep disorders (insomnia), three CBD formulations for Reload, Relax, and Repair, and the VapePod vaporization delivery device. The Company's R&D lab is set up in the Weizmann Science Park. The Company's clinical and validation activities, including safety and efficiency tests, are conducted in Israel. The Company is selling its initial products in Europe. It is also engaged in conducting research and development (R&D) to develop cannabis oil formulas, medical-grade vaporizers, and various non-smoking consumption solutions.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.